Calagua, C., Russo, J., Sun, Y., Schaefer, R., Lis, R., Zhang, Z., . . . Ye, H. (2017). Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide. Clinical cancer research, 23(22), 6812-6822. https://doi.org/10.1158/1078-0432.CCR-17-0807
Chicago Style (17th ed.) CitationCalagua, Carla, et al. "Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate Plus Prednisone and Leuprolide." Clinical Cancer Research 23, no. 22 (2017): 6812-6822. https://doi.org/10.1158/1078-0432.CCR-17-0807.
MLA (9th ed.) CitationCalagua, Carla, et al. "Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate Plus Prednisone and Leuprolide." Clinical Cancer Research, vol. 23, no. 22, 2017, pp. 6812-6822, https://doi.org/10.1158/1078-0432.CCR-17-0807.